Evidence map›Paper›PMID 28072620›Full record

ArticleClinical nuclear medicine2017

Fibrous Dysplasia Mimicking Malignancy on 68Ga-DOTATATE PET/CT.

Georgios Z Papadakis, Corina Millo, Samira M Sadowski, Apostolos H Karantanas, Ulas Bagci, Nicholas J Patronas

Open access · greenAbstract readCase Reports
In one paragraph

Article in Clinical nuclear medicine, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 13 citations in OpenAlex.

  1. Review
  2. Comparison ofScientific reports · 2025
    Article
  3. Article
  4. PET/CT and PET/MRI in ophthalmic oncology (Review).International journal of oncology · 2020
    Review
  5. The value ofBMC medical imaging · 2017
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 3 countries.

Georgios Z PapadakisFrom the *Radiology and Imaging Sciences, Warren Grant Magnuson Clinical Center, †PET Department; Clinical Center, and ‡Endocrine Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD; §Endocrine and Thoracic Surgery, University Hospitals of Geneva, Geneva, Switzerland; ∥Department of Radiology, Medical School, University of Crete, Greece; and ¶Center for Research in Computer Vision, Electrical and Computer Science Department, University of Central Florida, Orlando, FL.
Corina Millo
Samira M Sadowski
Apostolos H Karantanas
Ulas Bagci
Nicholas J Patronas
National Institutes of Health Clinical Center · USUniversity Hospital of Geneva · CHUniversity of Central Florida · USUniversity of Crete · GR

Funding

Intramural NIH HHS Z99 CL999999Intramural NIH HHS Z99 DE999999
6 · The paper itself

Abstract

Fibrous dysplasia of the bone is a developmental benign skeletal disorder characterized by replacement of normal bone and normal bone marrow with abnormal fibro-osseous tissue. We report on a case of a biopsy-proven fibrous dysplasia lesion in the left temporal bone, with intensely increased activity (SUVmax, 56.7) on Ga-DOTATATE PET/CT. The presented data indicate cell surface overexpression of somatostatin receptors by fibrous dysplastic cells and highlight the need of cautious management of Ga-DOTATATE-avid bone lesions, which could mimic malignancy especially in patients with history of neuroendocrine tumors.

Indexed as

Organometallic CompoundsPositron Emission Tomography Computed TomographyRadiopharmaceuticalsAgedDiagnosis, DifferentialFibrous Dysplasia of BoneHumansMaleNeuroendocrine Tumorsgallium Ga 68 dotatateOrganometallic CompoundsRadiopharmaceuticals

Identifiers

PMID28072620
PMCPMC5290189
OpenAlexW2571697776

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.